Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)

[1]  Jung Weon Lee,et al.  ␣5␤1 Integrin Protects Intestinal Epithelial Cells from Apoptosis through a Phosphatidylinositol 3-kinase and Protein Kinase B– Dependent Pathway Materials and Methods Cell Cultures Stable Transfectants Evaluating the Expression of Integrin Subunits Tunel Assay by Flow Cytometry Annexin V Assay Plat , 1999 .

[2]  Y. Kudo,et al.  Reduced expression of p27Kip1 correlates with an early stage of cancer invasion in oral squamous cell carcinoma , 2000 .

[3]  F. Prósper,et al.  Opposing effects of engagement of integrins and stimulation of cytokine receptors on cell cycle progression of normal human hematopoietic progenitors. , 2000, Blood.

[4]  M Chilosi,et al.  Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. , 2000, Blood.

[5]  W. Dalton,et al.  Integrin-Mediated Drug Resistance in Multiple Myeloma , 2000, Leukemia & lymphoma.

[6]  M. Weller,et al.  p27 modulates cell cycle progression and chemosensitivity in human malignant glioma. , 1999, Biochemical and biophysical research communications.

[7]  Christopher Haslett,et al.  Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo , 1999, Nature Medicine.

[8]  Andrea C. Carrano,et al.  Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. , 1999, Genes & development.

[9]  A. Hakem,et al.  The Cyclin-dependent Kinase Cdk2 Regulates Thymocyte Apoptosis , 1999, The Journal of experimental medicine.

[10]  A. Krämer,et al.  Adhesion to fibronectin stimulates proliferation of wild-type and bcr/abl-transfected murine hematopoietic cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. Dalton,et al.  Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines , 1999 .

[12]  S. Shankland,et al.  Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). , 1999, The Journal of clinical investigation.

[13]  M. Haugg,et al.  p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells , 1999, Oncogene.

[14]  M. Fornaro,et al.  p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma. , 1999, The Journal of clinical investigation.

[15]  Z. Kam,et al.  p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry , 1999, Oncogene.

[16]  J. Willis,et al.  p27 cell‐cycle inhibitor is inversely correlated with lymph node metastases in right‐sided colon cancer , 1999, Journal of clinical laboratory analysis.

[17]  J. Erhardt,et al.  Ectopic p21WAF1 Expression Induces Differentiation-specific Cell Cycle Changes in PC12 Cells Characteristic of Nerve Growth Factor Treatment* , 1998, The Journal of Biological Chemistry.

[18]  C. Lowell,et al.  A β1 integrin signaling pathway involving Src‐family kinases, Cbl and PI‐3 kinase is required for macrophage spreading and migration , 1998, The EMBO journal.

[19]  W. J. Pledger,et al.  Cyclin D3-associated kinase activity is regulated by p27kip1 in BALB/c 3T3 cells. , 1998, Molecular biology of the cell.

[20]  A. Pozzi,et al.  Integrin α1β1 Mediates a Unique Collagen-dependent Proliferation Pathway In Vivo , 1998, The Journal of cell biology.

[21]  Robert S. Kerbel,et al.  E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1 , 1998, The Journal of cell biology.

[22]  S. Retta,et al.  β1D Integrin Inhibits Cell Cycle Progression in Normal Myoblasts and Fibroblasts* , 1998, The Journal of Biological Chemistry.

[23]  T. Hunter,et al.  Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells , 1998, Oncogene.

[24]  M. Andreeff,et al.  Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. , 1998, Cancer research.

[25]  J. Brugge,et al.  Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation , 1997, Molecular and cellular biology.

[26]  C. Verfaillie,et al.  Monoclonal antibody crosslinking of the alpha 4 or beta 1 integrin inhibits committed clonogenic hematopoietic progenitor proliferation. , 1997, Experimental hematology.

[27]  A. Aplin,et al.  Integrin-mediated Activation of MAP Kinase Is Independent of FAK: Evidence for Dual Integrin Signaling Pathways in Fibroblasts , 1997, The Journal of cell biology.

[28]  W. J. Pledger,et al.  The role of p27kip1 in the in vitro differentiation of murine keratinocytes. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[29]  F. Giancotti,et al.  The Adaptor Protein Shc Couples a Class of Integrins to the Control of Cell Cycle Progression , 1996, Cell.

[30]  R. Kerbel,et al.  Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents , 1996, Nature Medicine.

[31]  R. Mannix,et al.  Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells. , 1996, Cancer research.

[32]  W. J. Pledger,et al.  Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells , 1996, Molecular and cellular biology.

[33]  James M. Roberts,et al.  Requirement of p27Kip1 for Restriction Point Control of the Fibroblast Cell Cycle , 1996, Science.

[34]  James M. Roberts,et al.  Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein , 1996, The Journal of cell biology.

[35]  C. Verfaillie,et al.  Activation-dependent alpha5beta1 integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells. , 1996, Blood.

[36]  M. Fornaro,et al.  The Novel Structural Motif Gln795–Gln802 in the Integrin β1C Cytoplasmic Domain Regulates Cell Proliferation (*) , 1995, The Journal of Biological Chemistry.

[37]  M. Schwartz,et al.  Inhibition of cell cycle progression by the alternatively spliced integrin beta 1C. , 1995, Science.

[38]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[39]  C. Verfaillie,et al.  Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. , 1995, The Journal of clinical investigation.

[40]  John Calvin Reed,et al.  The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  James M. Roberts,et al.  Human cyclin E, a nuclear protein essential for the G1-to-S phase transition , 1995, Molecular and cellular biology.

[42]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[43]  James M. Roberts,et al.  Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.

[44]  J. Bohnsack,et al.  Activation of beta 1 integrin fibronectin receptors on HL60 cells after granulocytic differentiation. , 1994, Blood.

[45]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[46]  M. Bissell,et al.  Multi‐faceted regulation of cell differentiation by extracellular matrix , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  L. Pilarski,et al.  Expression of multiple β1 integrins on circulating monoclonal B cells in patients with multiple myeloma , 1993 .

[48]  K. Kohn,et al.  Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. , 1993, Blood.

[49]  H. F. Barker,et al.  The role of adhesion molecules in multiple myeloma. , 1997, Leukemia & lymphoma.

[50]  S. Hanks,et al.  Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[51]  U. Strausfeld,et al.  Cyclin a is required for the onset of DNA replication in mammalian fibroblasts , 1991, Cell.

[52]  B. Teicher,et al.  Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. , 1990, Science.

[53]  F. Giancotti,et al.  Elevated levels of the α 5 β 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells , 1990, Cell.

[54]  R. Sutherland,et al.  Effects of intercellular contact on repair of radiation damage. , 1972, Experimental cell research.